PubMed

Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA.

Clin Infect Dis. 2009 Nov 15;49(10):1570-8.PMID: 19845472 [PubMed - in process]Related articles

Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.

Gold HT, Hall MJ, Blinder V, Schackman BR.

Cancer. 2009 Sep 1;115(17):3858-67.PMID: 19517472 [PubMed - indexed for MEDLINE]Related articles

Achieving effective antidepressant pharmacotherapy in primary care: the role of depression care management in treating late-life depression.

Bao Y, Post EP, Ten TR, Schackman BR, Bruce ML.

J Am Geriatr Soc. 2009 May;57(5):895-900.PMID: 19484846 [PubMed - indexed for MEDLINE]Related articles

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.

Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR 3rd, Sloan CE, Sax PE, Walensky RP.

Clin Infect Dis. 2009 Mar 15;48(6):806-15.PMID: 19193111 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PE.

AIDS. 2008 Oct 1;22(15):2025-33.PMID: 18784465 [PubMed - indexed for MEDLINE]Related articlesFree article

Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.

Ribaudo HJ, Kuritzkes DR, Lalama CM, Schouten JT, Schackman BR, Acosta EP, Gulick RM.

J Infect Dis. 2008 Apr 1;197(7):1006-10.PMID: 18419537 [PubMed - indexed for MEDLINE]Related articles

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

Schackman BR, Teixeira PA, Weitzman G, Mushlin AI, Jacobson IM.

Med Decis Making. 2008 Mar-Apr;28(2):233-42. Epub 2008 Mar 18.PMID: 18349430 [PubMed - indexed for MEDLINE]Related articles

Can urban methadone patients complete health utility assessments?

Teixeira PA, Schackman BR.

Patient Educ Couns. 2008 May;71(2):302-7. Epub 2008 Mar 7.PMID: 18314295 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost of antiretroviral therapy in Haiti.

Koenig SP, Riviere C, Leger P, Severe P, Atwood S, Fitzgerald DW, Pape JW, Schackman BR.

Cost Eff Resour Alloc. 2008 Feb 14;6:3.PMID: 18275615 [PubMed - in process]Related articlesFree article

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.

Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer WA 3rd, Shikuma C, Johnson VA, Fiscus SA, D'Aquila RT, Schackman BR, Acosta EP, Gulick RM.

J Infect Dis. 2008 Mar 15;197(6):867-70.PMID: 18269317 [PubMed - indexed for MEDLINE]Related articles

Sexually active HIV-positive patients frequently report never using condoms in audio computer-assisted self-interviews conducted at routine clinical visits.

Schackman BR, Dastur Z, Ni Q, Callahan MA, Berger J, Rubin DS.

AIDS Patient Care STDS. 2008 Feb;22(2):123-9.PMID: 18260803 [PubMed - indexed for MEDLINE]Related articles

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.

Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM.

J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):547-54.PMID: 18193496 [PubMed - indexed for MEDLINE]Related articles

Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.

Schackman BR, Scott CA, Sax PE, Losina E, Wilkin TJ, McKinnon JE, Swindells S, Weinstein MC, Freedberg KA.

Clin Infect Dis. 2007 Oct 15;45(8):1062-70. Epub 2007 Sep 4.PMID: 17879926 [PubMed - indexed for MEDLINE]Related articlesFree article

Preventing vertical hepatitis C virus transmission.

Schackman BR, Oneda K.

Clin Infect Dis. 2007 Sep 15;45(6):802. No abstract available. PMID: 17712770 [PubMed - indexed for MEDLINE]Related articles

Does higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs.

Schackman BR, Rojas EG, Gans J, Falco M, Millman RB.

Subst Abuse Treat Prev Policy. 2007 Jul 31;2:23.PMID: 17672900 [PubMed - in process]Related articlesFree article

Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.

Schackman BR, Neukermans CP, Fontain SN, Nolte C, Joseph P, Pape JW, Fitzgerald DW.

PLoS Med. 2007 May;4(5):e183.PMID: 17535105 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.

Gulick RM, Lalama CM, Ribaudo HJ, Shikuma CM, Schackman BR, Schouten J, Squires KE, Koletar SL, Pilcher CD, Reichman RC, Klingman KL, Kuritzkes DR.

AIDS. 2007 Apr 23;21(7):813-23.PMID: 17415036 [PubMed - indexed for MEDLINE]Related articles

Offers of hepatitis C care do not lead to treatment.

Schackman BR, Teixeira PA, Beeder AB.

J Urban Health. 2007 May;84(3):455-8.PMID: 17394085 [PubMed - indexed for MEDLINE]Related articlesFree article

Design issues in initial HIV-treatment trials: focus on ACTG A5095.

Ribaudo HJ, Kuritzkes DR, Schackman BR, Acosta EP, Shikuma CM, Gulick RM.

Antivir Ther. 2006;11(6):751-60.PMID: 17310819 [PubMed - indexed for MEDLINE]Related articles

Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment.

Schackman BR, Freedberg KA, Goldie SJ, Weinstein MC, Swartz K.

Health Care Financ Rev. 2005 Summer;26(4):67-80.PMID: 17288069 [PubMed - indexed for MEDLINE]Related articles